CancerDrs

Lung Cancer clinical trials in Hawaii

9 actively recruiting lung cancer trials at 6 sites across Hawaii.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting NIH

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT04267848
Sites in Hawaii:
  • Hawaii Cancer Care Inc - Waterfront Plaza — Honolulu, Hawaii
  • Island Urology — Honolulu, Hawaii
  • Queen's Cancer Cenrer - POB I — Honolulu, Hawaii
  • Queen's Medical Center — Honolulu, Hawaii
  • Straub Clinic and Hospital — Honolulu, Hawaii
View on ClinicalTrials.gov →
Phase 3 Recruiting NIH

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizuma…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT06096844
Sites in Hawaii:
  • Kaiser Permanente Moanalua Medical Center — Honolulu, Hawaii
View on ClinicalTrials.gov →
Phase 2, Phase 3 Recruiting Industry

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates fo…

Sponsor: Mirati Therapeutics Inc.
NCT ID: NCT04613596
Sites in Hawaii:
  • Local Institution - 007-897 — Honolulu, Hawaii
  • Local Institution - Unk005 — Honolulu, Hawaii
View on ClinicalTrials.gov →
Phase 2, Phase 3 Recruiting Industry

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs grow out of control. The purpose of this study is to assess adverse events and change in disease activity "when telisotuzumab adizutecan i…

Sponsor: AbbVie
NCT ID: NCT07005102
Sites in Hawaii:
  • Kaiser Permanente Moanalua Medical Center /ID# 275942 — Honolulu, Hawaii
View on ClinicalTrials.gov →
Phase 2 Recruiting Network

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-subcutaneous (SC) works in treating patients patients with MET amplification non-small cell lung cancer. Amivantamab-SC is a drug that reduces extra copies of the M…

Sponsor: SWOG Cancer Research Network
NCT ID: NCT06116682
Sites in Hawaii:
  • Hawaii Cancer Care Inc - Waterfront Plaza — Honolulu, Hawaii
  • Queen's Cancer Cenrer - POB I — Honolulu, Hawaii
  • Queen's Medical Center — Honolulu, Hawaii
  • Straub Clinic and Hospital — Honolulu, Hawaii
  • Queen's Cancer Center - Kuakini — Honolulu, Hawaii
View on ClinicalTrials.gov →
Phase 2 Recruiting Industry

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other…

Sponsor: Reunion Neuroscience Inc
NCT ID: NCT07002034
Sites in Hawaii:
  • Hawaii Pacific Neuroscience — Honolulu, Hawaii
View on ClinicalTrials.gov →
Recruiting Academic/Other

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

This study evaluates cancer-related weight and muscle mass loss, symptoms, and physical function (cachexia) in patients undergoing treatment for colorectal, lung, or pancreatic cancer that cannot be removed by surgery (unresectable) or is …

Sponsor: University of Rochester
NCT ID: NCT06073431
Sites in Hawaii:
  • Hawaii Cancer Care Inc - Waterfront Plaza — Honolulu, Hawaii
  • Queen's Cancer Cenrer - POB I — Honolulu, Hawaii
  • Queen's Medical Center — Honolulu, Hawaii
  • Straub Clinic and Hospital — Honolulu, Hawaii
  • Queen's Cancer Center - Kuakini — Honolulu, Hawaii
View on ClinicalTrials.gov →
NA Recruiting NIH

The Vanguard Study: Testing a New Way to Screen for Cancer

The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for mult…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT06995898
Sites in Hawaii:
  • Kaiser Permanente Moanalua Medical Center — Honolulu, Hawaii
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-12